International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-Driven Chemotherapy versus Standard Adjuvant Chemotherapy in completely Resected Stage II-IIIA Non-Small Cell Lung Cancer.
暂无分享，去创建一个
C. Kropf-Sanchen | G. Scagliotti | A. Ceribelli | S. Novello | E. Stoelben | R. Chiari | C. Grohé | L. Porcu | M. Schena | M. Reck | M. Serke | F. Griesinger | A. Bearz | G. Schmid‐Bindert | C. Manegold | O. Caffo | M. Geissler | G. Folprecht | A. Follador | T. Wehler | V. Gregorc | L. Irtelli | A. Santo | I. Colantonio | G. Wiest | G. Valmadre | N. Dickgreber | A. Morabito | V. Monica | V. Torri | S. Kurz | A. Meyer | D. Ladage | C. Cauchi | G. Borra | P Pedrazzoli